Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease

被引:300
|
作者
Yates, Clara M. [1 ]
Calder, Philip C. [2 ]
Rainger, G. Ed [1 ]
机构
[1] Univ Birmingham, Sch Clin & Expt Med, Ctr Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England
[2] Univ Southampton, Fac Med, Human Dev & Hlth Acad Unit, Southampton SO16 6YD, Hants, England
关键词
Omega-3 polyunsaturated fatty acid; Eicosapentaenoic acid; Docosahexaenoic acid; Inflammation; Eicosanoid; Resolvin; FISH-OIL SUPPLEMENTATION; TUMOR-NECROSIS-FACTOR; RANDOMIZED CONTROLLED-TRIAL; PROLIFERATOR-ACTIVATED RECEPTORS; CYTOKINE-INDUCED EXPRESSION; EUROPEAN PROSPECTIVE COHORT; PLACEBO-CONTROLLED TRIAL; ALPHA-LINOLENIC ACID; NF-KAPPA-B; DOCOSAHEXAENOIC ACID;
D O I
10.1016/j.pharmthera.2013.10.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Omega-3 (n-3) polyunsaturated fatty acids (n-3 PUFAs) have well documented anti-inflammatory properties, and consequently therapeutic potential in chronic inflammatory diseases. Here we discuss the effects of n-3 PUFAs on various inflammatory pathways and how this leads to alterations in the function of inflammatory cells, most importantly endothelial cells and leukocytes. Strong evidence indicates n-3 PUFAs are beneficial as a dietary supplement in certain diseases such as rheumatoid arthritis; however for other conditions such as asthma, the data are less robust. A clearer understanding of the pharmacology of n-3 PUFAs will help to establish targets to modulate chronic inflammatory diseases. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:272 / 282
页数:11
相关论文
共 50 条
  • [31] Omega-3 polyunsaturated fatty acids and mood disorders
    Astorg, Pierre
    OCL-OILSEEDS AND FATS CROPS AND LIPIDS, 2007, 14 (3-4) : 202 - 207
  • [32] Omega-3 polyunsaturated fatty acids and metabolic syndrome
    Kawada, Tomoyuki
    CLINICAL NUTRITION, 2020, 39 (07) : 2319 - 2319
  • [33] OMEGA-3 POLYUNSATURATED FATTY-ACIDS IN CHRONIC RENAL-INSUFFICIENCY
    BILO, HJG
    VANDERHEIDE, JJH
    GANS, ROB
    DONKER, AJM
    NEPHRON, 1991, 57 (04) : 385 - 393
  • [34] Omega-3 polyunsaturated fatty acids and anxiety disorders
    Ross, Brian M.
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2009, 81 (5-6): : 309 - 312
  • [35] Omega-3 polyunsaturated fatty acids: photoprotective macronutrients
    Pilkington, Suzanne M.
    Watson, Rachel E. B.
    Nicolaou, Anna
    Rhodes, Lesley E.
    EXPERIMENTAL DERMATOLOGY, 2011, 20 (07) : 537 - 543
  • [36] Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Diseases
    Lavie, Carl J.
    Milani, Richard V.
    Mehra, Mandeep R.
    Ventura, Hector O.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (07) : 585 - 594
  • [37] Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease
    Jump, Donald B.
    Lytle, Kelli A.
    Depner, Christopher M.
    Tripathy, Sasmita
    PHARMACOLOGY & THERAPEUTICS, 2018, 181 : 108 - 125
  • [38] Omega-3 Polyunsaturated Fatty Acids and Oxylipins in Neuroinflammation and Management of Alzheimer Disease
    Devassy, Jessay Gopuran
    Leng, Shan
    Gabbs, Melissa
    Monirujjaman, Md
    Aukema, Harold M.
    ADVANCES IN NUTRITION, 2016, 7 (05) : 905 - 916
  • [39] Target patients for polyunsaturated omega-3 fatty acids in cardiovascular disease prevention
    Kopec, Grzegorz
    Podolec, Piotr
    KARDIOLOGIA POLSKA, 2009, 67 (11) : 1299 - 1303
  • [40] Potential treatment of Parkinson's disease with omega-3 polyunsaturated fatty acids
    Li, Peng
    Song, Cai
    NUTRITIONAL NEUROSCIENCE, 2022, 25 (01) : 180 - 191